Top Health News Briefs: Delayed Launches, Defended Roles, and New Approvals

This summary provides an update on current health news. Highlights include Philip Morris delaying its IQOS launch, pharmaceutical middlemen defending their business model, Moderna co-founder Robert Langer stepping down, and other notable approvals in the healthcare sector.

Philip Morris International has delayed the test-launch of its heated tobacco device, IQOS, in the U.S. until the fourth quarter, affecting its annual forecast for the business.

Pharmaceutical middlemen defended their business model at a Congressional hearing amid accusations of raising patient costs by promoting expensive treatments over cheaper alternatives.

Moderna co-founder Robert Langer announced he will step down from the vaccine maker's board on August 5.

In other news, Novo Nordisk's weight-loss drug Wegovy received UK approval to lower heart risks, and UN agencies pushed for increased measles vaccinations in Bosnia after a deadly outbreak.